WallStreetZenWallStreetZen

NASDAQ: VRDN
Viridian Therapeutics Inc Stock Ownership - Who owns Viridian Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Viridian Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Jennifer TousignantCLO2026-08-1910,000$24.50
$245.00kSell
Jennifer TousignantCLO2026-08-194,212$24.50
$103.19kSell
Jennifer TousignantCLO2026-08-1910,000$14.41
$144.10kBuy
Radhika TripuraneniMed2026-08-1440,000$13.21
$528.40kBuy
Fairmount Funds Management LLCDirector2026-05-111,176,470$17.00
$20.00MBuy
Seth HarmonChief Financial Officer2026-03-032,031$30.19
$61.32kSell
Stephen F. MahoneyPresident and CEO2026-03-037,627$29.32
$223.62kSell
Thomas W. BeethamChief Operating Officer2026-03-033,138$29.32
$92.01kSell
Stephen F. MahoneyPresident and CEO2026-03-037,408$30.19
$223.65kSell
Jennifer TousignantChief Legal Officer2026-03-031,724$29.32
$50.55kSell

1 of 2

VRDN insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when VRDN insiders and whales buy or sell their stock.

VRDN Shareholders

What type of owners hold Viridian Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Fairmount Funds Management LLC8.41%9,531,779$195.12MInsider
Logos Global Master Fund LP5.30%6,000,000$122.82MInsider
Atlas Venture Fund VII L P2.77%3,142,580$64.33MInsider
Bruce Booth2.77%3,142,580$64.33MInsider
Remeditex Ventures LLC2.39%2,706,563$55.40MInsider
John W. Creecy2.39%2,706,563$55.40MInsider
Bennett S. Lebow2.35%2,662,070$54.49MInsider
Kyle Lefkoff1.86%2,107,870$43.15MInsider
Frazier Life Sciences Public Fund LP1.33%1,505,200$30.81MInsider
Samuel D. Riccitelli0.50%571,370$11.70MInsider

1 of 3

VRDN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
VRDN0.12%32.00%Net BuyingNet Buying
SLS0.04%5.15%Net Selling
VERA0.11%44.99%Net SellingNet Selling
MLYS0.11%52.52%Net SellingNet Selling
NRIX0.11%8.16%Net SellingNet Selling
View Top Biotech Stocks

Viridian Therapeutics Stock Ownership FAQ

Who owns Viridian Therapeutics?

Viridian Therapeutics (NASDAQ: VRDN) is owned by 0.12% institutional shareholders, 32.00% Viridian Therapeutics insiders, and 67.88% retail investors. Fairmount Funds Management LLC is the largest individual Viridian Therapeutics shareholder, owning 9.53M shares representing 8.41% of the company. Fairmount Funds Management LLC's Viridian Therapeutics shares are currently valued at $195.12M.

If you're new to stock investing, here's how to buy Viridian Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.